Market Performance
BridgeBio Oncology Therapeutics Inc. (NASDAQ:BBOT) surged 5.5% in today's trading, closing at $9.44.
The Healthcare stock traded 13,392.98277 shares, below its average daily volume of 237,220 shares.
BridgeBio Oncology Therapeutics Inc. (NASDAQ:BBOT) surged 5.5% in today's trading, closing at $9.44.

At publication ·
BridgeBio Oncology Therapeutics Inc. (NASDAQ:BBOT) · big mover up
At a glance
BridgeBio Oncology Therapeutics Inc. (NASDAQ:BBOT) surged 5.5% in today's trading, closing at $9.44.
The Healthcare stock traded 13,392.98277 shares, below its average daily volume of 237,220 shares.
BridgeBio Oncology Therapeutics Inc. has a market capitalization of $1.0B. The stock has traded year-to-date.
Sharp single-day moves like this rally in BridgeBio Oncology Therapeutics Inc. are often driven by news catalysts — earnings surprises, analyst actions, sector developments, or broader market conditions. Investors should identify the specific driver before making trading decisions, as the sustainability of the move depends on whether the catalyst changes the fundamental outlook.
BridgeBio Oncology Therapeutics Inc. currently trades at $9.44, positioning the stock at the 31th percentile of its 52-week range ($7.00 — $14.87). This range context helps investors assess whether the stock is trading near support, resistance, or fair value relative to its recent history.
Related Tools: View BBOT Stock Page
Price movements can be driven by earnings, analyst actions, or sector trends. Check the latest on our BBOT news page.
See full price history and interactive charts on our BBOT chart page.
Current market data
NASDAQ · BBOT
Keep reading
earnings ·
analyst ·
price ·
earnings ·